RSS

PharmaCell

Lonza has announced its successful acquisition of PharmaCell, a European cell and gene contract manufacturer. more

News

CiMaas, a developer of cellular immunotherapy for cancer, and PharmaCell, a contract manufacturer for cellular therapies and regenerative medicine in Europe, are collaborating in the clinical development of CiMaas’ products. more

News